Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR+9.3%
5Y CAGR-3.7%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+9.3%/yr
vs -35.8%/yr prior
5Y CAGR
-3.7%/yr
Recent acceleration
Acceleration
+45.1pp
Accelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 12.79% |
| 2024 | 39.94% |
| 2023 | 20.04% |
| 2022 | 9.80% |
| 2021 | 3.42% |
| 2020 | 15.46% |
| 2019 | 21.99% |
| 2018 | 57.82% |
| 2017 | 95.77% |
| 2016 | 61.72% |